SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-242231
Filing Date
2020-09-09
Accepted
2020-09-09 16:40:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d26565d424b5.htm 424B5 626252
2 GRAPHIC g26565g15q88.jpg GRAPHIC 103464
3 GRAPHIC g26565g73u99.jpg GRAPHIC 38276
  Complete submission text file 0001193125-20-242231.txt   822739
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235817 | Film No.: 201166898
SIC: 2834 Pharmaceutical Preparations